现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • Ilorasertib hydrochloride
Ilorasertib hydrochloride的可视化放大

Ilorasertib hydrochloride

A multi-kinase inhibitor

价格
0-13680
Ilorasertib hydrochloride的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajcx14908
  • CAS: 1847485-91-9
  • 别名: ABT-348 hydrochloride
  • 分子式: C25H22ClFN6O2S
  • 分子量: 525
  • 纯度: >98%
  • 溶解度: DMSO: 41.67 mg/mL (79.37 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

Ilorasertib is a multi-kinase inhibitor.1 It inhibits Aurora C, VEGFR1, VEGFR2, FLT3, colony-stimulating factor 1 receptor (CSF1R), and Aurora B (IC50s = 1, 1, 2, 1, 3, and 7 nM, respectively). It also inhibits PDGFRα, PDGFRβ, c-Kit, VEGFR3, and Aurora A (IC50s = 11, 13, 20, 43, and 120 nM, respectively). Ilorasertib inhibits autophosphorylation of Aurora A, -B, and -C in HeLa cells with IC50 values of 189, 13, and 13 nM, respectively. It inhibits proliferation of a variety of cancer cells, including MV4-11 acute myeloid leukemia (AML), SUP-B15 acute lymphocytic leukemia (ALL), and H1299 non-small cell lung cancer (NSCLC) cells (IC50s = 0.3, 4, and 2 nM, respectively). It decreases histone H3 phosphorylation in blood-borne tumor cells in an engrafted mouse model of leukemia when administered at a dose of 25 mg/kg and reduces tumor growth in fibrosarcoma, pancreatic carcinoma, ALL, and multiple myeloma mouse xenograft models.


1.Glaser, K.B., Li, J., Marcotte, P.A., et al.Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesJ. Pharmacol. Exp. Ther.343(3)617-627(2012)

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服